Product Images Acyclovir

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Acyclovir NDC 51407-852 by Golden State Medical Supply, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

51407-852-01LB - Acyclovir Caps - Rev. 1223.jpg - 51407 852 01LB Acyclovir Caps Rev. 1223

51407-852-01LB - Acyclovir Caps - Rev. 1223.jpg - 51407 852 01LB   Acyclovir Caps   Rev. 1223

This text appears to be a description of a medication called Acyclovir. The medication is available in capsule form, with each capsule containing 200 mg of Acyclovir. It is recommended to store the capsules in a tight container, away from light and moisture. The medication should be kept out of the reach of children. The recommended storage temperature is between 20°C and 25°C (68°F and 77°F).*

Structural Formula - acy03 0000 01

Structural Formula - acy03 0000 01

Table 1 - acy03 0000 02

Table 1 - acy03 0000 02

This text provides information about the pharmacokinetic characteristics of Acyclovir, a medication used to treat viral infections. The table shows the range for various parameters, including plasma protein binding (9% to 1033%), plasma elimination half-life (25 to 1033 hours), and average oral bioavailability (10% to 20%). It also mentions that bioavailability decreases with increasing dose.*

Table 2 - acy03 0000 03

Table 2 - acy03 0000 03

This text provides information about the peak and trough concentrations of Acyclovir at steady state for different doses (200 mg, 400 mg, and 800 mg). The table shows the values for Coax (presumably Cmax, the peak concentration) and C irough (presumably Cmin, the trough concentration) in meg/mL for each dose.*

Table 3 - acy03 0000 04

Table 3 - acy03 0000 04

Dosage modification for renal impairment is provided in Table 3. The table presents the normal dosage, adjusted dosage regimen, creatinine clearance, dose in milligrams (mg), and dosing interval for different scenarios. The dosing intervals vary based on creatinine clearance levels. The adjusted dosage regimen for each scenario is described in terms of the frequency of administration (every 4, 8, or 12 hours) and the recommended dosage (200, 400, or 800 mg). The text provides specific information regarding dosage modification for renal impairment.*

Imprint CTI 114 - acy03 0000 05

Imprint CTI 114 - acy03 0000 05

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.